CIK 0001638097
- Non-accelerated filer
- Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 25327151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- 4 Open-market buy Director bought 18,000 shares at $1.24 ($22,320)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 28,721 shares (grant or award)
- 4 Grant or award Director acquired 25,371 shares (grant or award)
- 4 Grant or award Director acquired 30,157 shares (grant or award)
- 4 Grant or award Director acquired 38,294 shares (grant or award)
- 4 Grant or award Director acquired 26,329 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 11,000 shares at $1.81 ($19,912)
- 4 Grant or award Chief Executive Officer acquired 180,702 shares (grant or award)
- 4 Grant or award Chief of R&D acquired 26,316 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 26,316 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Operating Officer acquired 26,316 shares (grant or award)
- 4 Option exercise Director acquired 23,952 shares (option exercise)
- 4 Grant or award Director acquired 6,922 shares (grant or award)
- 4 Grant or award Director acquired 8,038 shares (grant or award)
- 4 Grant or award Director acquired 8,216 shares (grant or award)
- 4 Grant or award Director acquired 10,717 shares (grant or award)
- 4 Grant or award Director acquired 7,100 shares (grant or award)
Page 2 of 7 · 126 filings